tm
Seeing Is Believing
tm
Seeing Is Believing
ATRA is currently covered by 8 analysts with an average potential upside of $8.89 (95.45%) from yesterday's end of day stock price of $0.66. Atara Biotherapeutics activity chart has currently 48 price targets and 68 ratings on display.
Analysts average stock forecasts to be materialized ratio is 45.06% with an average time for these price targets to be met of 81.7 days.
Highest price target for ATRA is $16, Lowest price target is $16, average price target is $16.
Most recent stock forecast was given by SALIM SYED from MIZUHO on 09-Nov-2023. First documented stock forecast 15-Dec-2015.
Currently, out of the existing stock ratings of ATRA - 20 which are a Buy (83.33%), 3 which are a Sell (12.5%), 1 which are a Hold (4.17%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1
$0.34 (51.52%)
25 days ago
0/3 (0%)
$14.67 (153.99%)
Buy
28
$26.52 (1791.89%)
5 months 20 days ago
1/4 (25%)
$14.24 (361.67%)
123
Buy
6 months 25 days ago
1/1 (100%)
$17.5 (59.32%)
26
Sell
1 years 3 months 25 days ago
3/3 (100%)
$-0.58 (-2.53%)
12
Sell
3
$2.34 (354.55%)
8
1 years 4 months 14 days ago
12/13 (92.31%)
$-2.85 (-3.73%)
248
What is ATRA (Atara Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?
